跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CliniMACS CD19 Reagent - Magnetic cell separation system reagent - TGA Drug Approval Details
Approvals
/
TGA
/
CliniMACS CD19 Reagent - Magnetic cell separation system reagent
Approved
STANDARD
CliniMACS CD19 Reagent - Magnetic cell separation system reagent
Miltenyi Biotec Australia Pty Limited
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
2f8feb0dddffa7c6
Company
Miltenyi Biotec Australia Pty Limited
Type
Standard
Approval Details
Approval Id
2f8feb0dddffa7c6
Product Name
CliniMACS CD19 Reagent - Magnetic cell separation system reagent
Artg Id
514086
Artg Name
Miltenyi Biotec Australia Pty Limited - CliniMACS CD19 Reagent - Magnetic cell separation system reagent
Sponsor
Miltenyi Biotec Australia Pty Limited
Artg Date
2025-09-30
Registration Type
Device
Therapeutic Good Type
Medical devices
Licence Status
A
Licence Category
INC
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
2f8feb0dddffa7c6
Type
Standard
Back to TGA Approvals
